Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Nike, MarketAxess, Hershey, UPS, Elevance Health, J&J, PepsiCo, Pfizer ... cash-flow-based dividend payout ratio of 55% aren’t exceptional, but look strong for a well-established company.

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...

A holistic or integrative approach to hair loss considers the hair growth cycle and hair loss from a nutritional, ...

Alten specialises in engineering and IT services and has a global presence in over 30 countries. The company describes itself as a “leading technological partner” for major industrial clients and has ...

Sumitomo Chemical Company, Limited ( OTCPK:SOMMY) Q3 2025 Results Conference Call February 3, 2025 3:00 AM ET Takato Watabe - Morgan Stanley MUFG Securities Makio Yamada - Mizuho Securities Go ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most number of shares in the company ... In the chart below, we zoom in ...

Pfizer Inc. (NYSE:PFE – Get Free Report) shares traded up 2.9% on Wednesday following a stronger than expected earnings report. The company traded as high as $26.69 and last traded at $26.62.